GMP grade retronectin 2.5 MG
Ended Awarded Last action
- Contract number
- HHSN26100001
- Awardee
-
Takara Bio Usa, Inc. UEI SCQNFFL3RJD9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,600
Award facts
- Opportunity
-
- N02RC4258962 Solicitation number
- Procurement of Retronectin for the production of genetically modified PBL for adoptive cell transfer protocols Award Notice · Posted Aug 8, 2014
- Contract value 100% obligated
- $12,600.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Mountain View, CA 94043, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Takara Bio Usa, Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2014.
How much is contract HHSN26100001 worth?
The government has obligated $12,600 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a delivery order under HHSN261201400019I, an indefinite delivery contract.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award